←Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma
Wojciech Jurczak
MD, PhD
🏢Maria Sklodowska-Curie National Research Institute of Oncology🌐Poland
Professor of Hematology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Wojciech Jurczak has led numerous trials of BTK inhibitors including zanubrutinib in marginal zone lymphoma and other indolent B cell malignancies. He is an active international investigator contributing to European and global lymphoma studies.
Share:
🧪Research Fields 研究领域
marginal zone lymphoma trials
zanubrutinib
PI3K inhibitors
European lymphoma studies
follicular lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Wojciech Jurczak 的研究动态
Follow Wojciech Jurczak's research updates
留下邮箱，当我们发布与 Wojciech Jurczak（Maria Sklodowska-Curie National Research Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment